MYC and neoplasm: Additionally, Buguzhi, Guizhi, Mudanpi, and Fuling downregulated the “MYC targets v1” and “G2M checkpoint” gene sets, which are closely related to the inhibition of tumor cell proliferation and cell cycle progression.